CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management

CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management

Fluorescence in situ hybridization (FISH) is a confirmatory test to establish a diagnosis of inv(16)/t(16;16) AML. However, incidental findings and their clinical diagnostic implication have not been systemically studied. We studied 1629 CBFB FISH cases performed in our institution, 262 (16.1%), 123...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard K. Yang, Gokce A. Toruner, Wei Wang, Hong Fang, Ghayas C. Issa, Lulu Wang, Andrés E. Quesada, Beenu Thakral, Keyur P. Patel, Guang Peng, Shujuan Liu, C. Cameron Yin, Gautam Borthakur, Zhenya Tang, Sa A. Wang, Roberto N. Miranda, Joseph D. Khoury, L. Jeffrey Medeiros, Guilin Tang
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
FISH
<i>CBFB rearrangement</i>
<i>CBFB-MYH11</i>
RT-PCR
atypical findings
additional chromosome16 aberrations (AC16As)
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/e574dae0bf48403aa1f3b9fd1c82d0bc
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/e574dae0bf48403aa1f3b9fd1c82d0bc

Similar Items